Abstract:Favel L Mondesir, 1 Emily B Levitan, 2 Gargya Malla, 2 Reshmi Mukerji, 3 April P Carson, 2 Monika M Safford, 4 Janet M Turan 5 1 Division of Cardiovascular Medicine, School of Medicine, University of Utah, Salt Lake City, UT, USA; 2 Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA; 3 School of Medicine, Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA; 4 Department of Medicine, Weill Cornell Medicine, New York, NY, USA; 5 Department of Health Care Organization and Policy, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA Correspondence: Favel L Mondesir Division of Cardiovascular Medicine, School of Medicine, University of Utah, Room 4A100, 30 N 1900 E, Salt Lake City, UT 84132, USA Tel +1-801-587-9048 Email favel.mondesir@hsc.utah.edu Background: Few qualitative studies have explored factors influencing medication adherence among people with coronary heart disease (CHD) or CHD risk factors. We explored how factors related to the patient (e.g. self-efficacy), social/economic conditions (e.g. social support and cost of medications), therapy (e.g. side effects), health condition (e.g. comorbidities), and the healthcare system/healthcare team (e.g. support from healthcare providers and pharmacy access) influence medication adherence, based on the World Health Organization Multidimensional Adherence Model (WHO-MAM). Methods: We conducted 18 in-depth qualitative interviews from April to July 2018 with ambulatory care patients aged ≥45 years (8 black men, 5 black women, 2 white men, and 3 white women) who were using medications for diabetes, hypertension, dyslipidemia and/or CHD. We used thematic analysis to analyze the data, and sub-themes emerged within each WHO-MAM dimension. Findings: Patient-related factors included beliefs about medications as important for self and faith; the desire to follow the advice of family, friends, and influential others; and self-efficacy. Social/economic factors included observations of social network members and information received from them; social support for medication adherence and pharmacy utilization; and economic influences. Therapy-related barriers included side effects and medicine schedules. Only a few participants mentioned condition-related factors. Healthcare system/healthcare team-related factors included support from doctors and pharmacists; and ease of pharmacy access and utilization. Conclusion: These results underscore the need for multidimensional interventions aimed at improving medication adherence and overall health of patients with CHD and CHD risk factors. Keywords: medication adherence, qualitative research, coronary heart disease, diabetes, hypertension, dyslipidemia

Factors influencing adherence to clinical practice guidelines in patients with suspected chronic coronary syndrome: a qualitative interview study in the ambulatory care sector in Germany

Barriers and facilitators of adherence to clinical practice guidelines in Germany—A systematic review

Guidelines or mindlines? - implementing a new CKD guideline in German primary care

Patient and physician related factors of adherence to evidence based guidelines in diabetes mellitus type 2, cardiovascular disease and prevention: a cross sectional study

Quality of Critical Care Clinical Practice Guidelines: Assessment with AGREE II Instrument.

A tailored intervention for the detection of patients with coronary heart disease and mental or cognitive comorbidities in the German primary care setting: qualitative evaluation of implementation success

Health-related quality of life among general practice patients with differing chronic diseases in Germany: Cross sectional survey

Physicians’ Adherence to Clinical Guidelines on the Chronic Heart Failure Diagnosis and Treatment: Changes Over 2 Years of the Document’s Existence

German general practitioners' experiences of managing post-COVID-19 syndrome: A qualitative interview study

Assessing Adherence to Clinical Practice Guidelines Among Primary Care Physicians in Bahrain: A Cross-sectional Study

Development and implementation of a treatment pathway to reduce coronary angiograms - lessons from a failure

Quality of health care for patients with coronary heart disease and comorbid mental disorders: a prospective cohort study

Barriers and facilitators to the use of clinical practice guidelines in osteoarthritis care: a qualitative study among German physiotherapists

[The German National Disease Management Guideline "Chronic Heart Failure"]

Factors facilitating the implementation of a clinical decision support system in primary care practices: a fuzzy set qualitative comparative analysis

Timely integration of specialist palliative home care (SPHC) for patients with congestive heart failure, chronic obstructive pulmonary disease and dementia: qualitative evaluation of the experiences of SPHC physicians in the KOPAL trial

Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors

Regional and patient-related factors influencing the willingness to use general practitioners as coordinators of the treatment in northern Germany - results of a cross-sectional observational study

Implementing advance care planning in heart failure: a qualitative study of primary healthcare professionals

Diagnosis, Treatment, and Management for Chronic Coronary Syndrome: A Systematic Review of Clinical Practice Guidelines and Consensus Statements

Chronic non-communicable diseases and health awareness of patients: An observational study analysing the health adaptive behaviours through self-care skills